Clinical Trials Logo

Growth clinical trials

View clinical trials related to Growth.

Filter by:

NCT ID: NCT03003117 Recruiting - Physical Activity Clinical Trials

The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)

ECAIL
Start date: April 3, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a randomized controlled trial among 800 socially disadvantaged pregnant women and their families to test the effectiveness of a multi-component home visitation nutrition program, compared to usual care, in promoting healthy feeding practices, lifestyle behaviors and growth in young children.

NCT ID: NCT02860026 Withdrawn - Growth Clinical Trials

Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas

Start date: October 2016
Phase: N/A
Study type: Interventional

This clinical trial will compare the growth and tolerance of infants who consume an investigational cow's milk-based infant formula to those who consume a marketed cow's milk-based infant formula through approximately 4 months of age.

NCT ID: NCT02695784 Recruiting - Microbiota Clinical Trials

Probiotics After Discharge

PAD
Start date: September 1, 2017
Phase: Phase 4
Study type: Interventional

The influence of the preterm gut microbiota in health and disease has been well established. However, relatively little is known about how the microbiome changes after discharge and its relationship with growth, health and disease outcomes in the preterm population. This study aims to follow a cohort of preterm infants and explore the relationship of the later microbiome ('after discharge') with later growth and health outcomes in infancy. The study will also explore the effect of timing of stopping routinely administered probiotics on the post-discharge microbiome, infant feeding and outcomes such as colic. The investigators aim to longitudinally follow 40 infants born before 32 weeks gestation who have also taken part in the investigators microbiome study during their NICU stay (SERVIS REC No: 10/H0908/39) and where microbiomic sampling has been adequately achieved. The investigators will collect stool at and beyond the time of anticipated discharge (beyond 34 weeks) targeted to include pre- and post-weaning, and again at a year. Actual discharge timing of these infants varies, and is usually latest in the most immature infants, allowing an assessment of the influence of physical location (NICU vs home) as well as increasing age. Using 16S ribosomal RNA amplicon analysis, the investigators will assess bacterial colonisation of the gut and measure infant weight, length and head circumference at each time point. The investigators will use a parent questionnaire to assess daily crying time, parents' perceptions of colic severity using a visual analogue scale as well as vomiting and constipation for the two weeks before sampling.

NCT ID: NCT02490852 Completed - Growth Clinical Trials

Study of Nutritional Suitability of a New Infant Formula for Term Infants

Start date: August 2015
Phase: N/A
Study type: Interventional

This is a growth study of full-term infants. The growth of infants fed the investigational formula will be compared with infants fed a control formula. A breastfeeding arm will be used as reference.

NCT ID: NCT02481531 Completed - Growth Clinical Trials

Growth and Tolerance of Cow's Milk-Based Infant Formulas

Start date: July 2015
Phase: N/A
Study type: Interventional

This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.

NCT ID: NCT02469454 Completed - Contraception Clinical Trials

Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development

Start date: June 2015
Phase: Phase 4
Study type: Interventional

This study aims to assess whether there is change in the growth and development of newborns whose mothers will have a etonogestrel (ENG) releasing implant inserted in the first 24 to 48 hours of delivery compared with those with standard implant insertion (6 week postpartum).

NCT ID: NCT02440503 Completed - Body Composition Clinical Trials

How Infant Diets Would Affect Growth in Early Childhood

FYI-FU
Start date: June 2014
Phase: N/A
Study type: Observational

The investigators research group conducted a feeding study in 2012 (IRB 07-0003) that included breastfed infants consuming different infant solid foods. The investigators results showed that different solid foods, especially the protein content of the food, is important on infant's gut bacteria profile and growth. Although the first year of life is critical in obesity development later in life, data are very limited on the effect of protein from solid foods, an important component of infant diet, especially in breast-fed infants. In this study, the investigators will re-contact these participants, who are now in their early childhood (~5 years old), to evaluate the long-term effect of various macronutrient quantities in solid foods, by assessing the participants' growth, body composition, and gut bacteria profile.

NCT ID: NCT02410057 Active, not recruiting - Sleep Clinical Trials

Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula

Start date: November 2014
Phase: N/A
Study type: Interventional

Formula composition is developed to resemble breast milk as close as possible, but there are still considerable differences between formula and breast milk composition, probably resulting in higher risk of overweight in childhood and higher incidence of infections in formula-fed infants. Protein levels are still higher and constituents such as alpha-lactalbumin lower in formula than in breast milk. By adding more alpha-lactalbumin to formula, rich in tryptophan, the resulting amino acid composition will allow further reduction of protein in formula. The investigators intend to include 320 infants, where 80 will be exclusively breastfed and the remainder assigned in a double blind, controlled, randomized manner to one of three formula groups; two experimental, protein reduced formula with two different levels of alpha-lactalbumin and one group given standard infant formula. The intervention period is from 4-8 weeks until 6 months of age. The infants will be followed by growth parameters, blood-, urine- and fecal biomarkers and health parameters until 5 years of age. The experimental formula will possibly result in growth, metabolism and gut microbiota as well as health parameters more similar to those of breastfed infants

NCT ID: NCT02377973 Completed - Obesity Clinical Trials

Diet and Well-being of Young Danish Children Born by Obese Mothers

SKOT II
Start date: January 2011
Phase: N/A
Study type: Observational

The overall aim is to provide a detailed description of growth, development and risk factors for later disease, especially obesity and metabolic disease in infants born by obese mothers and to compare them with a group of infants born by mothers without any restriction in prepregnancy BMI (SKOT I).

NCT ID: NCT02178514 Completed - Growth Clinical Trials

BabyNes Nutrition System Growth Study

Start date: December 2014
Phase: N/A
Study type: Interventional

Our main research question is: Do infants fed with BabyNes Nutrition System grow in agreement with the WHO reference? Our second question is: Do infants fed with BabyNes Nutrition System have a metabolic profile closer to breastfed infants? In order to answer both questions an observational trial will be carried out for 12 months in order to measure weight and to calculate the weight for age z-scores according to the WHO reference. A breastfeeding group will be used as reference for the metabolic parameters measured in blood of infants from Chinese background. The effect of the Babynes formulas will be compared to the metabolic values obtained from this breast-feeding reference group.